WELCOME TO OCUTRX MEDICAL

Ocutrx has filed multiple patents to protect the key intellectual property covering the headset concept and the complex algorithms used to reposition video pixels from blurred vision areas to adjacent areas having viable vision. While the company’s proprietary video technology is well positioned to disrupt and penetrate many areas, Ocutrx’s primary focus is to apply this video processing to assist low vision patients in the large $40 billion vision care market. A secondary focus is to allow the Oculenz Glasses to form the basis of a best-of-class “open system” Augmented Reality Glasses. The headset and lenses are very lightweight, less than 200 grams, and the D-Pad “dongle” houses a controller for mode setting and battery, which can be charged on a separate system. The Headset contains Mini-HDMI and USB-C connectors with BlueTooth® and WiFi wireless connections for a truly “tether-less” system.

OCUTRX vision technologies offers one of the first computer mediated reality (cmr) glasses for managing the effects of macular degeneration and other central eye defects.

Patient Actuating Diagnostic Mode

A revolutionary aspect of the Oculenz Glasses is that the Patient can set to “Diagnostics” mode and self-refine and adjust the Pixel Manipulation to match changes or advancing of the disease size and shapes.

Doctor Alerts for Significant Eye Changes

The Oculenz Glasses automatically alert Physicians when a Patient’s diagnostic shows a severe percentage change in vision or disease symptoms from the diagnostics mode to alert doctors of potential needed medical treatment.

Oculenz Sentrx Object Recognition

The Oculenz Glasses also include object identification software which will audibly alert a wearer of obstacles such as furniture, doors, stairs and curbs.

OCULENZ TO HELP PATIENTS BEYOND MEDICAL TREATMENT

Ocutrx innovations address central eye defects with new computer mediated augmented reality technologies.

According to Dr. Lars Freisberg, M.D., “The value of the technology is so great that it cannot yet be measured.”  Ocutrx will enter into patient evaluations with their Medical Oculenz ARwear in 2018.  The Oculenz Macular Degeneration Solution provides an excellent opportunity for patients whose macular degeneration no longer responds to other medical treatment to once again enjoy “functional vision” so they can read and accomplish daily routine tasks.

13,000,000

30,000,000

22,000,000

$343 billion

EFFECTED BY ARMD IN US

ARMD WORLDWIDE

ARMD US POPULATION BY 2050

GLOBAL COST OF VISUAL IMPAIRMENT

WHAT MAKES OCUTRX DIFFERENT?

From the lightest wearable form factor to state-of-the-art graphics processing, Ocutrx™ Oculenz™ glasses provides best-of-class augmented reality experience.

MACULAR DEGENERATION

MAINTAIN INDEPENDENCE

AIDS IN RESTORING FUNCTIONAL VISION

Age-related Macular Degeneration (AMD) is a condition where damage to the retina causes patients to have impaired central vision and see a blackened central spot.

This technology is the first to aid in restoring functional sight and offer patients an enhanced quality of life, and improved independence in their life.

These retinal conditions can devastate a patient’s life and prevent reading, seeing faces, driving and performing simple daily tasks.

OCULENZ™ WEARABLE GLASSES

VISION SPECIALIST

TRACK PROGRESS

Through Computer Mediated Reality (CMR) individual pixels are relocated from impaired regions to functional areas of the eye.

The wearable glasses are initially set up at a doctor’s office, but the performance can be easily adjusted by the patient at home.

 

Our diagnostic mode tracks the areas of the eye with impairments and notifies your doctor with any significant changes.

 

MEDTRX SYSTEM

The Medical Oculenz solution has a MEDTRX system which includes real-time Blood Pressure and Heart Rate monitoring.

SEE MORE

 

"With the Oculenz the idea is that the patient senses the entire image and learns to disregard the defect area through ‘neural adaptation’ due to the ‘plasticity of the brain,’ said Dr. R. Wade Crow, M.D., Neural Ophthalmologist and Associate Professor of Neuro-Ophthalmology at the University of California-Irvine and member of the Ocutrx IMAB, “Working with visual input, the brain can train itself to not see redundant or unnecessary things." – Dr. Wade Crow

PATIENT ZERO

Brig. Gen. Richard C. Freeman (USAF Ret.)

Combining a highly awarded military career with entrepreneurial pursuits, General Freeman was a man of many accomplishments. He advanced in rank from Lieutenant to Brigadier General over his 35-year military career as a jet-fighter pilot and Wing Commander of the Oklahoma Air National Guard and served a term as the Adjutant General to the Governor of the State of Oklahoma. He declined several military promotions over the years, so he could keep flying, his passion. In business, he started out as a top national salesman of Beechcraft aircraft; selling airplanes all over the world. He later purchased and ran a number of successful companies.

 

Richard was a family man with five children of his own. Then, in the late 70’s he and his wife, Gwyn became the guardians for five children of one family after their mother died, as their father, also an Air Force pilot had been killed years earlier while flying on active duty in Viet Nam. Later, the Freemans became the “sponsor” of three more children, who were born in Viet Nam and had escaped as refugees. Finally, the Freemans became a sponsor of a young man from India, where later the Freeman’s built an Orphanage for children in the Imphal area of India. Richard always considered all 14 kids as his own.

 

Among his notables, Richard received a Commendation from the Governor of Louisiana for putting over 400 laid-off workers back to work, after he purchased a pipe-fitting manufacturing plant in Opelousas, Louisiana which had been shuttered due to environmental issues. He also served as President, then later as Executive Chairman of PC Designs, an early computer manufacturing company he purchased in the 1980’s when desktop computers were just becoming a phenomenon. The company later became on of the largest suppliers of computer products to the State of California.

 

Also, during the 1990’s he co-invented, along with his sons Michael, Mitchael, and son-in-law Chad Boss the first cellular streaming video device, which was licensed by all the major cell companies of that day. The technology and patents were later sold to Samsung. The FirstLook® Video Streaming Mobile Video Device was the foundation of IEEE 802.11(n) MIMO standards, still used today in sending video over smartphones. The team also won two Academy of Television Arts and Sciences Emmy Awards in 1994 for the technologies’ contributions to television.

 

But, then, while at the top of his game, most of his activities came to a halt when he was diagnosed with Macular Degeneration --- which deteriorated rapidly --- caused, in part, by his over 30,000 flying hours where he was above the clouds and much closer to the damaging effects of the sun. He had to give up his passion of flying, and then had to even stop driving a car, and became unable to read newspapers, emails, recognize faces or watch television.

 

Gathering the original team who invented streaming mobile video around him, he declared that there must be a way to help people like him with central eye disease to become functional again. The story began when his sons took him to see a new ‘curved’ television and stepping into the curve, he remarked how much easier it was to interpret the action when more of the information was displayed onto the periphery of his eyes. From that sparked discovery was born the idea to take streaming video information and manipulate it where all the information was projected onto the eyes, but none of the information was projected onto the part of the eye where the defect existed. In late 2013, and beginning with a circuit board, some improvised software and a pair of virtual reality goggles, the original Ocutrx team of Richard Freeman, Michael Freeman, Mitchael Freeman, Chad Boss and Jordan Boss began to work on the integration of hardware and software refining a pixel manipulation methodology and algorithms which could define Richards’ defect in each eye and then re-position the video images on the portions of his eye where there were no deficits. Richard reveled in being “Patient Zero” on a technology he believed would help millions to recover functionality in their lives, just like him.

 

In one of the first uses of the device Richard remarked, “I can see your nose --- I haven’t seen your nose for years!” With further improvements, he was once again able to read and send emails, a task which put him firmly back into his normal daily routine. It was realized during those early trials that VR was not the solution, because of the restricted real-world vision, and the Team began looking for an Augmented Reality solution all around the world. The invention was reduced to a provisional patent in early 2014 and the project gathered steam. Unfortunately, Richard had to undergo heart surgery in the fall of 2014, and tragically succumbed to the after-effects of that surgery in November 2014.

 

After a time of mourning, Michael Freeman founded Ocutrx in 2015, along with Raytrx, its affiliate, in honor of Brig. General Freeman and the rest of the Team picked up the work to create a mass production model of the Augmented Reality headwear which would incorporate the now greatly expanded millions of code library of software. Ocutrx has grown rapidly since its humble beginnings, adding personnel, engineers, and multi-state offices, but still, at its roots, Ocutrx is truly the vision of one man’s determination to find a way around a debilitating eye disease --- and get back into the game.

 

Our Valued Partners and Vendors bring bags of value to our product. Feel free to ask us about them.

+

Submitting Form...

The server encountered an error.

Form received.